Gene Therapy of Cancer : Methods and Protocols - used book

EAN (ISBN-13): 9780896037144
ISBN (ISBN-10): 0896037142
Hardcover
Publishing year: 2000
Publisher: Springer
645 Pages
Weight: 1,139 kg
Language: eng/Englisch

Book in our database since 2007-11-22T00:23:48+00:00 (London)
Detail page last modified on 2023-08-19T22:43:58+01:00 (London)
ISBN/EAN: 0896037142

ISBN - alternate spelling:
0-89603-714-2, 978-0-89603-714-4
Alternate spelling and related search-keywords:
Book author: walther, ulrike may, wolfgang stein, spring ulrike, ulrike steiner
Book title: cancer gene therapy, molecular medicine

---

Information from Publisher

Author: Wolfgang Walther; Ulrike Stein
Title: Methods in Molecular Medicine; Gene Therapy of Cancer - Methods and Protocols
Publisher: Humana Press; Humana Press
645 Pages
Publishing year: 2000-02-17
Totowa; NJ; US
Weight: 1,267 kg
Language: English
85,59 € (DE)
87,99 € (AT)
106,60 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; C; Oncology; Medicine; BC; EA; BB

Part I. Experimental Approaches to Cancer Gene Therapy. Immunotherapy/ Tumor vaccination. Immunizing Potential of Cytokine-Transduced Tumor Cells. Particle-Mediated Gene Transfer into Dendritic Cells: A Novel Strategy for the Induction of Immune Responses against Tumor Antigens. Cancer Gene Therapy with Heat Shock Protein-65 Gene. Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens. Suicide Gene Therapy. Selection of Cytochrome P450 Genes for Use in Prodrug Activation-Based Cancer Gene Therapy. Construction of P450-Expressing Tumor Cell Lines Using Retroviruses. In Vitro Methods for Evaluation of P450-Based Anticancer Gene Therapy. Tumor Models for Evaluation of P450 Gene Therapy In Vivo. Anti-Oncogene and Suppressor Gene Therapy. Intracellular Single-Chain Antibodies for Gene Therapy. Combined Adenoviral Transfer of Tumor Suppressor and Cell-Cycle Genes for Tumor-Cell Apoptosis. Antisense Gene Therapy. Inhibition of Cell Growth by Antisense Oligonucleotides Targeting the Growth-Related Protein Kinase c-raf. IGF-1 Antisense Strategies for Cancer Treatment. Ribozyme Gene Therapy. Anti-MDR1 Ribozyme Gene Therapy. Anti-c-erbB2 Ribozyme for Gene Therapy of Breast Cancer. Anti-K-ras Ribozyme Adenoviral Vector for Gene Therapy of Non-Small Cell Lung Cancer. Delivery Systems and Tumor Targeting. Green Fluorescent Protein Retroviral Vector: Generation of High-Titer Producer Cells and Virus Supernatant. HSV-1 Vectors for Gene Therapy of Experimental CNS Tumors. Intratumoral Injection of Naked DNA. Cationic Liposome Gene Transfer. In Vivo Particle-Mediated Gene Transfer for Cancer Therapy. Gene Targeting to Hepatomas (AFP). Adenovirus-Mediated Targeted Gene Therapy for Breast Cancer and for Purging Hematopoietic Stem-Cell Sources. Chemotherapy-Inducible Vector for Gene Therapy of Cancer. Alternative Approaches in Cancer Gene Therapy. Oncolytic Adenoviral Vectors. Genetically Modified Clostridium for Gene Therapy ofTumors. Tumor-Targeted Salmonella: Strain Development and Expression of the HSV-tK Effector Gene. Part II. Clinical Protocols for Cancer Gene Therapy. Immunotherapy/Tumor Vaccination. Ex Vivo Cytokine Gene Transfer in Melanomas by Using Particle Bombardment. Intratumoral Gene Transfer of the HLA-B7 Gene Into Colon Carcinoma Metastases. Hybrid Cell Vaccination in Patients with Metastatic Melanoma. Suicide Gene Therapy. Retroviral Transfer of the Herpes Simplex Virus-Thymidine Kinase (HSV-tK) Gene for the Treatment of Cancer. Gene Therapy for Treatment of Brain Tumors (HSV-tK In Vivo Gene Transfer): A Case Study. Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tk. Intratumoral Gene Transfer of the Cytosine Deaminase Gene for the Treatment of Breast Cancer. Anti-Oncogene and Suppressor Gene Therapy. Adenovirus-Mediated Wild-Type p53 Gene Transfer into Head and Neck Cancers. Direct DNA Injection (p53) into HCC Tumors. A Phase II Trial of Intratumoral Injection with Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and Neck. Antisense Gene Therapy. c-myb Antisense Oligonucleotide Therapeutics for Hematologic Malignancies. Ovarian Cancer Gene Therapy with BRCA1- An Overview. Methods for Chemoprotection and Chemosensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors to Modify Epithelian Neoplastic Cells. Index